What does CUSIP 88025U109 represent in this 13F holders report?

CUSIP 88025U109 is the security identifier for TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK used to aggregate holder disclosures.

How many institutions held TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK in Q2 2020?

141 institutional investors reported TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK for Q2 2020. Use the holders table for investor-level position and value details.

10x Genomics, Inc. - CLASS A COMMON STOCK (TXG)

CUSIP: 88025U109

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / CLASS A COMMON STOCK
Total 13F shares: 61,004,107
Total 13F value: $5,448,595,110
Share change: +12,718,270
Put/Call ratio: 32%
SEC-reported price per share: $89.31
Number of holders: 141
Value change: +$1,160,387,284
Number of buys: 105
Number of sells: 42
Shares outstanding: 118,868,985

Security key

88025U109

Report period

Q2 2020

Institutions

141

Top holders

TXG full security history Ownership snapshot Full 13F holder table 10x Genomics, Inc. SEC filings 10x Genomics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of TXG - 10x Genomics, Inc. - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Foresite Capital Manageme...

Disclosed value leader

Foresite Capital Manageme...

Comparable rows

15/15

Latest evidence

31 Mar 2020

13F Lead comparable stake: 5.5% Showing 1-6 of 15 holder rows.

Quick read

Foresite Capital Management II, LLC leads the comparable SEC ownership view at 5.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Foresite Capital Management II, LLC's linked filing trail.

Comparable ownership Top 5

Foresite Capital Management II, LLC 5.5%

Foresite Capital Management I, LLC 4.9%

MORGAN STANLEY 4.2%

SB INVESTMENT ADVISERS (UK) LTD 3.2%

FMR LLC 2.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Foresite Capital Management II, LLC	13F Company 13F	5.5%	$410,518,000 6,587,253 shares	—	31 Mar 2020
Foresite Capital Management I, LLC	13F Company 13F	4.9%	$360,728,000 5,788,317 shares	—	31 Mar 2020
MORGAN STANLEY	13F Company 13F	4.2%	$314,628,000 5,048,578 shares	—	31 Mar 2020
SB INVESTMENT ADVISERS (UK) LTD	13F Company 13F	3.2%	$239,074,000 3,836,232 shares	—	31 Mar 2020
FMR LLC	13F Company 13F	2.7%	$198,948,000 3,192,369 shares	—	31 Mar 2020
ALLIANCEBERNSTEIN L.P.	13F Company 13F	1.3%	$98,030,000 1,573,010 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

141

61,004,107

Rows available

141

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

102

Q2 2020 holders

141

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %